Search for Clinical Trial Results

Sponsored By

Fibromatosis, Aggressive - 25 Studies Found

Status Study
Completed Study Name: Toremifene in Treating Patients With Desmoid Tumors
Condition: Desmoid Tumor
Date: 1999-11-01
Interventions:
  • Drug: toremifene
  • Procedure: conventional s
Completed Study Name: Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Condition: Desmoid Tumor
Date: 2000-08-03
Interventions:
  • Drug: methotrexate Other Names
Completed Study Name: Radiation Therapy in Treating Patients With Aggressive Fibromatoses
Condition: Desmoid Tumor
Date: 2002-02-14
Interventions: Radiation: radiation therapy
Recruiting Study Name: PAZOPANIB Efficacy and Tolerance in Desmoids Tumors
Condition: Progressive Desmoids Tumors
Date: 2012-11-06
Interventions:
  • Drug: PAZOPANIB treatment

Recruiting Study Name: A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Condition: Desmoid Tumor
Date: 2010-12-06
Interventions: Drug: Sirolimus
  • Loading do
Active, not recruiting Study Name: Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Condition: Desmoid Tumor
Date: 2003-09-10
Interventions:
  • Drug: tamoxifen citrate Given

Recruiting Study Name: Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment
Condition: Desmoid Tumors
Date: 2015-06-04
Interventions: Device: "cryoprobes" Patient undergo percutaneous cryoablation of desmoid tumor, with cryoprob
Recruiting Study Name: National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)
Condition: Aggressive Fibromatosis
Date: 2016-07-15
Interventions:
  • Procedure: biopsy pre-therapeu
Active, not recruiting Study Name: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Condition:
  • Desmoid Tumors
  • Aggressive Fibromatosis Date: 2013-10-31
    Interventions: Drug: PF-03084014 Treatment with the selective small-molecule >=-secretase inhibitor PF- 3084014 caus
Active, not recruiting Study Name: Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Condition: Desmoid Type-fibromatosis
Date: 2015-01-28
Interventions: Drug: Toremifene Patients will receive 60 mg daily and then 180 daily in case of progression
Next >>>